These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33738713)

  • 1. Clinical Outcomes and Immune Metrics in Intratumoral Basophil-Enriched Gastric Cancer Patients.
    He X; Cao Y; Gu Y; Fang H; Wang J; Liu X; Lv K; Yu K; Fei Y; Lin C; Liu H; Zhang H; Li H; Xu J; Li R; He H
    Ann Surg Oncol; 2021 Oct; 28(11):6439-6450. PubMed ID: 33738713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of peripheral basophils with tumor M2 macrophage infiltration and outcomes of the anti-PD-1 inhibitor plus chemotherapy combination in advanced gastric cancer.
    Wu C; Qiu Y; Zhang R; Li X; Liang H; Wang M; Li F; Zhu M; Ye G; Liu H; Li G; Zhao L
    J Transl Med; 2022 Sep; 20(1):386. PubMed ID: 36058929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor clinical outcomes of intratumoral dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin-positive macrophages associated with immune evasion in gastric cancer.
    Liu X; Cao Y; Li R; Gu Y; Chen Y; Qi Y; Lv K; Wang J; Yu K; Lin C; Liu H; Zhang H; He H; Chen L; Zhang P; Shen Z; Qin J; Sun Y; Li H; Huang H; Zhang W; Xu J
    Eur J Cancer; 2020 Mar; 128():27-37. PubMed ID: 32109848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poor clinical outcomes and immunoevasive contexture in CXCL13+CD8+ T cells enriched gastric cancer patients.
    Jin K; Cao Y; Gu Y; Fang H; Fei Y; Wang J; Liu X; Lv K; He X; Lin C; Liu H; Li H; He H; Li R; Zhang H; Xu J
    Oncoimmunology; 2021 Apr; 10(1):1915560. PubMed ID: 33996266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-infiltrating podoplanin
    Liu X; Cao Y; Lv K; Gu Y; Jin K; He X; Fang H; Fei Y; Shi M; Lin C; Liu H; Li H; He H; Xu J; Li R; Zhang H
    Oncoimmunology; 2020 Nov; 9(1):1845038. PubMed ID: 33235820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latency-associated Peptide Identifies Immunoevasive Subtype Gastric Cancer With Poor Prognosis and Inferior Chemotherapeutic Responsiveness.
    Cao Y; He H; Li R; Liu X; Chen Y; Qi Y; Yu K; Wang J; Lin C; Liu H; Zhang H; Li H; Chen L; Zhang P; Shen Z; Huang H; Sun Y; Zhang W; Qin J; Xu J
    Ann Surg; 2022 Jan; 275(1):e163-e173. PubMed ID: 32511132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poor Clinical Outcomes and Immunoevasive Contexture in Intratumoral IL-10-Producing Macrophages Enriched Gastric Cancer Patients.
    Zhang H; Li R; Cao Y; Gu Y; Lin C; Liu X; Lv K; He X; Fang H; Jin K; Fei Y; Chen Y; Wang J; Liu H; Li H; Zhang H; He H; Zhang W
    Ann Surg; 2022 Apr; 275(4):e626-e635. PubMed ID: 32541216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral Foxp3
    Fei Y; Cao Y; Gu Y; Fang H; Chen Y; Wang J; Liu X; Lv K; He X; Lin C; Liu H; Li H; He H; Li R; Zhang H; Zhang W
    Cancer Immunol Immunother; 2022 Jan; 71(1):1-11. PubMed ID: 33978826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of intratumoural CD73 expression on prognosis and therapeutic response in patients with gastric cancer.
    He X; Gu Y; Cao Y; Hu B; Fang H; Fei Y; Lv K; Liu X; Wang J; Lin C; Liu H; Zhang H; Li H; Li R; He H; Xu J
    Eur J Cancer; 2021 Nov; 157():114-123. PubMed ID: 34508993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral CD103
    Gu Y; Chen Y; Jin K; Cao Y; Liu X; Lv K; He X; Lin C; Liu H; Li H; He H; Qin J; Li R; Zhang H; Zhang W
    Oncoimmunology; 2020 Nov; 9(1):1844402. PubMed ID: 33312758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-infiltrating Neutrophils is Prognostic and Predictive for Postoperative Adjuvant Chemotherapy Benefit in Patients With Gastric Cancer.
    Zhang H; Liu H; Shen Z; Lin C; Wang X; Qin J; Qin X; Xu J; Sun Y
    Ann Surg; 2018 Feb; 267(2):311-318. PubMed ID: 27763900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratumoral IL17-producing cells infiltration correlate with antitumor immune contexture and improved response to adjuvant chemotherapy in gastric cancer.
    Wang JT; Li H; Zhang H; Chen YF; Cao YF; Li RC; Lin C; Wei YC; Xiang XN; Fang HJ; Zhang HY; Gu Y; Liu X; Zhou RJ; Liu H; He HY; Zhang WJ; Shen ZB; Qin J; Xu JJ
    Ann Oncol; 2019 Feb; 30(2):266-273. PubMed ID: 30445581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of intratumoural CD96 expression on clinical outcome and therapeutic benefit in gastric cancer.
    Xu C; Fang H; Gu Y; Yu K; Wang J; Lin C; Zhang H; Li H; He H; Liu H; Li R
    Cancer Sci; 2022 Dec; 113(12):4070-4081. PubMed ID: 35997524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and validation of poor prognosis immunoevasive subtype of muscle-invasive bladder cancer with tumor-infiltrating podoplanin
    Zhou Q; Wang Z; Zeng H; Zhang H; Liu Z; Huang Q; Wang J; Chang Y; Bai Q; Liu L; Zhu Y; Xu L; Dai B; Guo J; Xia Y; Wang Y; Xu J
    Oncoimmunology; 2020 Apr; 9(1):1747333. PubMed ID: 33457092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TIM3
    Chen K; Gu Y; Cao Y; Fang H; Lv K; Liu X; He X; Wang J; Lin C; Liu H; Zhang H; He H; Xu J; Li H; Li R
    Br J Cancer; 2022 Jan; 126(1):100-108. PubMed ID: 34725458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumoral IL-1R1 expression delineates a distinctive molecular subset with therapeutic resistance in patients with gastric cancer.
    Zhang P; Gu Y; Fang H; Cao Y; Wang J; Liu H; Zhang H; Li H; He H; Li R; Lin C; Xu J
    J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35110359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune inactivation by APOBEC3B enrichment predicts response to chemotherapy and survival in gastric cancer.
    Xia S; Gu Y; Zhang H; Fei Y; Cao Y; Fang H; Wang J; Lin C; Zhang H; Li H; He H; Xu J; Li R; Liu H; Zhang W
    Oncoimmunology; 2021; 10(1):1975386. PubMed ID: 34552824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumoral IL22-producing cells define immunoevasive subtype muscle-invasive bladder cancer with poor prognosis and superior nivolumab responses.
    Zeng H; Liu Z; Wang Z; Zhou Q; Qi Y; Chen Y; Chen L; Zhang P; Wang J; Chang Y; Bai Q; Xia Y; Wang Y; Liu L; Zhu Y; Dai B; Guo J; Xu L; Zhang W; Xu J
    Int J Cancer; 2020 Jan; 146(2):542-552. PubMed ID: 31584197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor clinical outcomes and immunoevasive contexture in SIRPα
    Xu Z; Zeng H; Liu Z; Jin K; Chang Y; Wang Y; Liu L; Zhu Y; Xu L; Wang Z; Guo J; Xu J
    Urol Oncol; 2022 Mar; 40(3):109.e11-109.e20. PubMed ID: 34600802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-C motif chemokine 22 predicts postoperative prognosis and adjuvant chemotherapeutic benefits in patients with stage II/III gastric cancer.
    Wu S; He H; Liu H; Cao Y; Li R; Zhang H; Li H; Shen Z; Qin J; Xu J
    Oncoimmunology; 2018; 7(6):e1433517. PubMed ID: 29872564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.